(Q46729875)

24 December 2017

title

Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans (English)

1 reference

24 December 2017

0 references

1 reference

1 reference

4

David C Wright

1 reference

24 December 2017

author name string

A Brianne Thrush

1

1 reference

24 December 2017

George J Heigenhauser

2

1 reference

24 December 2017

Kerry L Mullen

3

1 reference

24 December 2017

David J Dyck

5

1 reference

24 December 2017

publication date

27 February 2008

1 reference

24 December 2017

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

published in

1 reference

24 December 2017

volume

294

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

R1205-12

1 reference

24 December 2017

Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Mechanisms of fatty acid-induced inhibition of glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

A prospective analysis of the HOMA model. The Mexico City Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Skeletal muscle lipid metabolism with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Nicotinic acid adenine dinucleotide phosphate: a new intracellular second messenger?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00909.2007

10.1152/AJPREGU.00909.2007

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18305020

1 reference

24 December 2017